-
-
Call more information
660-596-2224 -
Scrambler Therapy — in which an electronic device is used to block transmission of pain signals by providing non-pain information to the nerve fibres — is a viable option for the treatment of chemotherapy-induced peripheral neuropathy (CIPN), according to results of a small, prospective study presented on October 21 at the 2017 Annual Meeting of […]
Read MoreIntraperitoneal bupivacaine is an effective postoperative analgesic following laparascopic cholecystectomy, according to results of a meta-analysis presented here at the 2017 Annual Meeting of the American College of Surgeons (ACS). “Intraperitoneal bupivacaine instillation effectively reduces post-operative pain in patients who underwent laparoscopic cholecystectomy, specifically in the first 12 hours postoperatively,” stated lead author Linnelle Lao, […]
Read MoreIntraoperative administration of a fixed dose of dexmedetomidine is associated with a 35% decrease in postoperative opioid use and faster discharge from the post-anaesthesia care unit (PACU) in patients undergoing minimally invasive thoracic surgery, according to prospective research presented at the 2017 Annual Meeting of the American Society of Anesthesiologists (ASA). Multimodal analgesia is commonly […]
Read MoreDuloxetine is effective in alleviating chemotherapy-induced peripheral neuropathy (CIPN) in patients with advanced cancer, according to a study presented here at the 2017 ASCO Palliative Care in Oncology Symposium. “Duloxetine reduced pain in patients with CIPN, significantly in most cases,” said Sang Mi Ro, MD, Youido St. Mary’s Hospital, Medical College, Catholic University, Seoul, South […]
Read MoreMethadone is a pain-relief option for children with advanced cancer and chronic pain, according to a study presented here at the 2017 ASCO Palliative Care in Oncology Symposium. “Methadone as the first long-acting opioid in children with advanced cancer is both effective and safe,” said Kevin Madden, MD, The University of Texas MD Anderson Cancer […]
Read More